On this response article, we problem a core assumption that lies on the centre of a spherical desk dialogue concerning the Pharmacogenetics to Keep away from Lack of Listening to trial. The spherical desk regards a genetic check for a variant (mt.1555A>G) that will increase the chance of deafness if a service is given the antibiotic gentamicin. The concept is that fast testing can determine neonates in danger, offering a chance to stop giving an antibiotic which may trigger deafness. We problem the idea {that a} optimistic check unequivocally guides antibiotic alternative as a result of, apart from the chance of deafness, all antibiotics for neonatal sepsis are equal. We argue that this assumption is defective and has notably troubling ethical penalties. We declare that giving an alternative choice to gentamicin is probably offering inferior therapy and thereby could improve the chance of dying.
Mother and father and medical doctors are confronted with a horrible alternative because of optimistic point-of-care testing (POCT): give gold-standard therapy and danger deafness or give second line care and danger dying. Whereas we don’t point out a solution to this alternative, what we do argue is that such a deep and tough alternative is one that will make dad and mom want genetic testing was by no means undertaken, and due to this fact, contra some authors within the spherical desk, offers a cause to achieve particular consent for POCT. On this research, 60 isolates of A. baumannii had been collected from sufferers in a number of hospitals in Tehran, Iran. After analysis utilizing commonplace biochemical strategies, the sample of antibiotic susceptibility was decided utilizing the disk diffusion technique in response to CLSI tips. The adeA and adeS genes had been recognized by PCR technique.
The best resistance to Piperacillin and the bottom resistance to Gentamicin had been noticed. 6.6% of the isolates had solely adeA gene and adeS gene was noticed in 8.4% of isolates and each genes had been detected in 73.4% of the samples. Regardless of the excessive resistance of t A. baumannii o antibiotics and because of the excessive frequency of genes of adeA and adeS efflux pumps in A. baumannii isolates, it may be concluded that these efflux pumps could play an essential function in resistance of this bacterium. By figuring out the sample of antibiotic the resistance earlier than therapy, the resistance of this pathogen will be prevented in societies.
Triple Canal Occlusion for the Remedy of Intractable Menière’s Illness
Pioglitazone Ameliorates Gentamicin Ototoxicity by Affecting the TLR and STAT Pathways within the Early Postnatal Organ of Corti
Gentamicin antibody |
|||
10-G02A | Fitzgerald | 500 ug | EUR 591.6 |
Description: Mouse monoclonal Gentamicin antibody |
Gentamicin Antibody |
|||
abx021011-200ug | Abbexa | 200 ug | EUR 393.6 |
Gentamicin Antibody |
|||
abx021012-1mg | Abbexa | 1 mg | EUR 1144.8 |
Gentamicin Antibody |
|||
abx021013-1mg | Abbexa | 1 mg | EUR 577.2 |
Gentamicin Antibody |
|||
20-abx210193 | Abbexa |
|
|
Gentamicin monoclonal antibody |
|||
10R-11497 | Fitzgerald | 1 mg | EUR 1332 |
Description: Mouse anti- Gentamicin monoclonal antibody |
Gentamicin (GTM) Antibody |
|||
20-abx175177 | Abbexa |
|
|
Gentamicin [KLH] |
|||
DAG4484 | Creative Diagnostics | 1mg | EUR 1248 |
Gentamicin [HRP] |
|||
DAGA-032H | Creative Diagnostics | 1mg | EUR 1248 |
Gentamicin(GM) |
|||
AG022 | Unibiotest | 1 mg | EUR 627.6 |
Gentamicin-HRP |
|||
65-IG10 | Fitzgerald | 1 mg | EUR 716.4 |
Description: Conjugated Gentamicin-HRP hapten |
Gentamicin-BSA |
|||
80-1453 | Fitzgerald | 1 mg | EUR 781.2 |
Description: BSA conjugated Gentamicin Hapten |
Gentamicin-BSA |
|||
80-1454 | Fitzgerald | 1 mg | EUR 781.2 |
Description: BSA conjugated Gentamicin Hapten |
Gentamicin-OVA |
|||
80-1455 | Fitzgerald | 1 mg | EUR 781.2 |
Description: OVA conjugated Gentamicin Hapten |
Gentamicin-OVA |
|||
80-1456 | Fitzgerald | 1 mg | EUR 781.2 |
Description: OVA conjugated Gentamicin Hapten |
Gentamicin-BSA |
|||
80-IG10 | Fitzgerald | 25 mg | EUR 457.2 |
Description: Conjugated Gentamicin-BSA hapten |
Gentamicin(GM) |
|||
AT022 | Unibiotest | 1mg | EUR 1134 |
Gentamicin sulfate |
|||
GA7939-10G | Glentham Life Sciences | 10 g | EUR 122.4 |
Gentamicin sulfate |
|||
GA7939-1G | Glentham Life Sciences | 1 g | EUR 55.2 |
Gentamicin sulfate |
|||
GA7939-25G | Glentham Life Sciences | 25 g | EUR 189.6 |
Gentamicin sulfate |
|||
GA7939-5G | Glentham Life Sciences | 5 g | EUR 93.6 |
Gentamicin (sulfate) |
|||
HY-A0276 | MedChemExpress | 500mg | EUR 142.8 |
Gentamicin sulfate |
|||
B1270-1G | Biovision | each | EUR 170.4 |
Gentamicin sulfate |
|||
B1270-25G | Biovision | each | EUR 1136.4 |
Gentamicin sulfate |
|||
B1270-5G | Biovision | each | EUR 405.6 |
Gentamicin Solution, Gentamicin Solution, 50 mg/mL |
|||
CCM1123-010 | Bio Basic | 10 mL | EUR 76.86 |
Gentamicin ELISA Kit |
|||
DEIA047 | Creative Diagnostics | 96T | EUR 1238.4 |
Description: This kit can be used in quantitative and qualitative analysis of gentamicin residue in vaccine and cell culture. |
Gentamicin, 50mg/ml |
|||
CA003-001 | GenDepot | 10ml | EUR 109.2 |
Gentamicin ELISA kit |
|||
55R-2233 | Fitzgerald | 1 kit | EUR 837.6 |
Description: Gentamicin ELISA kit for use in research laboratory |
Gentamicin sulfate salt |
|||
20-abx082235 | Abbexa |
|
|
Gentamicin Sulfate USP |
|||
G006-25G | TOKU-E | 25 g | EUR 470.4 |
Gentamicin Sulfate USP |
|||
G006-5G | TOKU-E | 5 g | EUR 199.2 |
Gentamicin Sulfate EP |
|||
G007-25G | TOKU-E | 25 g | EUR 478.8 |
Gentamicin Sulfate EP |
|||
G007-5G | TOKU-E | 5 g | EUR 219.6 |
Gentamicin ELISA Kit |
|||
K4206-100 | Biovision | each | EUR 1188 |
Mouse Anti Gentamicin Monoclonal Antibody |
|||
DMABT-54913MG | Creative Diagnostics | 1 mg | EUR 920.4 |
Mouse Anti Gentamicin Monoclonal Antibody |
|||
DMABT-54914MG | Creative Diagnostics | 1 mg | EUR 920.4 |
Sheep Anti Gentamicin Polyclonal Antibody |
|||
DPBT-68266SG | Creative Diagnostics | 0.5 ml | EUR 920.4 |
Gentamicin ELISA Kit (OKAO00127) |
|||||||||||||
OKAO00127 | Aviva Systems Biology | 96 Wells | EUR 638.4 | ||||||||||
Description: Description of target: Gentamicin is a complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity:
|
Gentamicin C1 pentaacetate salt |
|||
GA1270-10MG | Glentham Life Sciences | 10 mg | EUR 783.6 |
Gentamicin C1 pentaacetate salt |
|||
GA1270-1MG | Glentham Life Sciences | 1 mg | EUR 204 |
Gentamicin C2 pentaacetate salt |
|||
GA2476-5MG | Glentham Life Sciences | 5 mg | EUR 418.8 |
Gentamicin C1a pentaacetate salt |
|||
GA4559-10MG | Glentham Life Sciences | 10 mg | EUR 514.8 |
Gentamicin C1a pentaacetate salt |
|||
GA4559-25MG | Glentham Life Sciences | 25 mg | EUR 964.8 |
0.1g Gentamicin Sulfate Powder |
|||
61-098-RA | Scientific Laboratory Supplies | EACH | EUR 58.37 |
1g Gentamicin Sulfate Powder |
|||
61-098-RF | Scientific Laboratory Supplies | EACH | EUR 76.38 |
Sd Gentamicin Gm-10 |
|||
231299 | Scientific Laboratory Supplies | PK10 | EUR 50.86 |
Gentamicin C1 Sulfate EvoPure® |
|||
G031-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C1a sulfate EvoPure® |
|||
G032-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C2 sulfate EvoPure® |
|||
G033-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C2a sulfate EvoPure® |
|||
G034-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin A sulfate EvoPure® |
|||
G035-10MG | TOKU-E | 10 mg | EUR 456 |
Gentamicin X2 sulfate EvoPure® |
|||
G036-2.5MG | TOKU-E | 2.5 mg | EUR 36 |
Gentamicin X2 sulfate EvoPure® |
|||
G036-PleaseContactusforPricing | TOKU-E | Please Contact us for Pricing | EUR 36 |
Gentamicin C2b sulfate EvoPure® |
|||
G062-10MG | TOKU-E | 10 mg | EUR 615.6 |
10mL Gentamicin Sulfate Liquid 5 |
|||
30-005-CR | Scientific Laboratory Supplies | PK10 | EUR 523.26 |
GTTR [Texas Red gentamicin conjugate] |
|||
24300 | AAT Bioquest | 100 ug | EUR 203 |
GTTR [Texas Red gentamicin conjugate] |
|||
24301 | AAT Bioquest | 1 mg | EUR 989 |
Gentamicin (serum/urine) ELISA Kit |
|||
K4315-100 | Biovision | each | EUR 907.2 |
Anti-Gentamicin antibody *Mouse anti-human, monoclonal IgG1* |
|||
V100270 | AAT Bioquest | 50 ug | EUR 367.2 |
Anti-Gentamicin antibody *Mouse anti-human, monoclonal IgG1* |
|||
V100271 | AAT Bioquest | 1 mg | EUR 1306.8 |
Gentamicin Sulfate Solution (50 mg/mL in Water) |
|||
G046-20ML | TOKU-E | 20 mL | EUR 132 |
TruStrip RDT Gentamicin rapid test strips, results is 2-10 mins, 50 strips/pk |
|||
DE-100200-RDT | Alpha Diagnostics | 1 pk | Ask for price |
HEPES-TL Supplement with BSA (Fract V), sodium pyruvate, and gentamicin to make HEPES-TALP (Tyrode's Albumin Lactate Pyruvate). |
|||
IVL01-500ML | Caisson Labs | 500 ml | EUR 104.4 |
Description: Supplement with BSA (Fract V), sodium pyruvate, and gentamicin to make HEPES-TALP (Tyrode's Albumin Lactate Pyruvate). |
HEPES-TL Supplement with BSA (Fract V), sodium pyruvate, and gentamicin to make HEPES-TALP (Tyrode's Albumin Lactate Pyruvate). |
|||
IVL01-6X500ML | Caisson Labs | 6 x 500 ml | EUR 226.8 |
Description: Supplement with BSA (Fract V), sodium pyruvate, and gentamicin to make HEPES-TALP (Tyrode's Albumin Lactate Pyruvate). |
IVF-TL Supplement with BSA (EFAF), sodium pyruvate, gentamicin, and heparin to make IVF-TALP (Tyrode's Albumin Lactate Pyruvate). |
|||
IVL02-100ML | Caisson Labs | 100 ml | EUR 90 |
Description: Supplement with BSA (EFAF), sodium pyruvate, gentamicin, and heparin to make IVF-TALP (Tyrode's Albumin Lactate Pyruvate). |
IVF-TL Supplement with BSA (EFAF), sodium pyruvate, gentamicin, and heparin to make IVF-TALP (Tyrode's Albumin Lactate Pyruvate). |
|||
IVL02-6X100ML | Caisson Labs | 6 x 100 ml | EUR 154.8 |
Description: Supplement with BSA (EFAF), sodium pyruvate, gentamicin, and heparin to make IVF-TALP (Tyrode's Albumin Lactate Pyruvate). |
SP-TL Supplement with BSA (Fract V), sodium pyruvate, and gentamicin to make SP-TALP (Tyrode's Albumin Lactate Pyruvate). |
|||
IVL03-100ML | Caisson Labs | 100 ml | EUR 86.4 |
Description: Supplement with BSA (Fract V), sodium pyruvate, and gentamicin to make SP-TALP (Tyrode's Albumin Lactate Pyruvate). |
SP-TL Supplement with BSA (Fract V), sodium pyruvate, and gentamicin to make SP-TALP (Tyrode's Albumin Lactate Pyruvate). |
|||
IVL03-6X100ML | Caisson Labs | 6 x 100 ml | EUR 126 |
Description: Supplement with BSA (Fract V), sodium pyruvate, and gentamicin to make SP-TALP (Tyrode's Albumin Lactate Pyruvate). |
ASAP1 antibody Antibody |
|||
DF8746 | Affbiotech | 200ul | EUR 420 |
CD11b Antibody Antibody |
|||
ABD2911 | Lifescience Market | 100 ug | EUR 525.6 |
anti- Antibody^Polyclonal antibody control antibody |
|||
LSMab09882 | Lifescience Market | 100 ug | EUR 525.6 |
ARHGDIA Antibody / RHOGDI Antibody |
|||
F54788-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
ARHGDIA Antibody / RHOGDI Antibody |
|||
F54788-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
Antibody |
|||
A1360-500 | Biovision | each | Ask for price |
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx123734 | Abbexa |
|
|
Anti-Glycolipid Antibody (AGA) Antibody |
|||
20-abx004855 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx014333 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx008109 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx033330-400ul | Abbexa | 400 ul | EUR 627.6 |
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx033330-80l | Abbexa | 80 µl | EUR 343.2 |
Anti-Glycolipid Antibody (AGA) Antibody |
|||
abx036399-100ug | Abbexa | 100 ug | EUR 469.2 |
Anti-Glycolipid Antibody (AGA) Antibody |
|||
abx230204-100ug | Abbexa | 100 ug | EUR 577.2 |
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319900 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319901 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319905 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319913 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx311665 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx324434 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx234901-100ug | Abbexa | 100 ug | EUR 661.2 |
Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ111530 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT4 Antibody antibody |
|||
STJ112276 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
Anti-Anti-MARCH9 Antibody antibody |
|||
STJ112609 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ25475 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ25477 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ25479 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ28365 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ28963 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
Anti-Anti-SEPT12 Antibody antibody |
|||
STJ117759 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118549 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118550 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH7 Antibody antibody |
|||
STJ118752 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT3 Antibody antibody |
|||
STJ118990 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ113941 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ114081 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-MARCH8 Antibody antibody |
|||
STJ114828 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
CLCN5 Antibody / CIC-5 antibody |
|||
RQ6462 | NSJ Bioreagents | 100ug | EUR 419 |
Description: The CLCN5 gene encodes the chloride channel Cl-/H+ exchanger ClC-5. This gene encodes a member of the ClC family of chloride ion channels and ion transporters. The encoded protein is primarily localized to endosomal membranes and may function to facilitate albumin uptake by the renal proximal tubule. Mutations in this gene have been found in Dent disease and renal tubular disorders complicated by nephrolithiasis. Alternatively spliced transcript variants have been found for this gene. |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|||
48169-100ul | SAB | 100ul | EUR 399.6 |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|||
48169-50ul | SAB | 50ul | EUR 286.8 |
Antibody Pair to ApoA-V antibody |
|||
10R-1876 | Fitzgerald | 100 ul | EUR 781.2 |
Description: Mouse monoclonal Antibody Pair to ApoA-V antibody |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-01mg | Virogen | 0,1 mg | EUR 321 |
Description: anti-CD22 monoclonal antibody |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: anti-CD22 monoclonal antibody |
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103034 | Abbexa |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103035 | Abbexa |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103036 | Abbexa |
|
|
Hepatitis C Virus Antibody (HCV) Antibody |
|||
abx023924-1mg | Abbexa | 1 mg | EUR 1446 |
Anti-Glycoprotein 210 Antibody (gp210) Antibody |
|||
abx233571-100ug | Abbexa | 100 ug | EUR 577.2 |
Anti Deoxyribonucleic Acid Antibody (DNA) Antibody |
|||
abx411057-50ug | Abbexa | 50 ug | EUR 710.4 |
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319902 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319903 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319904 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319906 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319907 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319908 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319914 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319915 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319916 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319929 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319930 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319931 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (HRP) |
|||
20-abx311666 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (FITC) |
|||
20-abx311667 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (Biotin) |
|||
20-abx311668 | Abbexa |
|
|
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
|||
AMM06679G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
Goat anti- human Antibody^Polyclonal antibody |
|||
LSMab09896 | Lifescience Market | 100 ug | EUR 525.6 |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D | Stressmarq | 0.1mg | EUR 424.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is unconjugated. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A390 | Stressmarq | 0.1mg | EUR 481.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 390. |